Industry Cautions FDA To Avoid ‘Overinterpreting’ Cosmetic Allergy Survey Results

In a March 5 statement, FDA Commissioner Scott Gottlieb included labeling disclosure of known cosmetic allergens among elements that could be included in a modernized system for cosmetics oversight. The agency’s planned consumer survey, designed to assess “allergy to cosmetics,” could help to inform exploratory steps in that direction.

Coming soon - sign with megaphone

More from Regulation

More from Policy & Regulation